168 related articles for article (PubMed ID: 18994656)
1. Carbocisteine for acute exacerbations of COPD.
Mohapatra PR; Aggarwal D
Lancet; 2008 Nov; 372(9650):1630-1; author reply 1631-2. PubMed ID: 18994656
[No Abstract] [Full Text] [Related]
2. Carbocisteine for acute exacerbations of COPD.
Waller P; Suissa S
Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
[No Abstract] [Full Text] [Related]
3. A PEACE-ful solution to COPD exacerbations?
Albert P; Calverley P
Lancet; 2008 Jun; 371(9629):1975-6. PubMed ID: 18555897
[No Abstract] [Full Text] [Related]
4. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.
Zheng JP; Kang J; Huang SG; Chen P; Yao WZ; Yang L; Bai CX; Wang CZ; Wang C; Chen BY; Shi Y; Liu CT; Chen P; Li Q; Wang ZS; Huang YJ; Luo ZY; Chen FP; Yuan JZ; Yuan BT; Qian HP; Zhi RC; Zhong NS
Lancet; 2008 Jun; 371(9629):2013-8. PubMed ID: 18555912
[TBL] [Abstract][Full Text] [Related]
5. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
Tatsumi K; Fukuchi Y;
J Am Geriatr Soc; 2007 Nov; 55(11):1884-6. PubMed ID: 17979906
[No Abstract] [Full Text] [Related]
6. Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis.
Zeng Z; Yang D; Huang X; Xiao Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2277-2283. PubMed ID: 28814855
[TBL] [Abstract][Full Text] [Related]
7. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
[TBL] [Abstract][Full Text] [Related]
8. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Hooper C; Calvert J
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):659-69. PubMed ID: 19281081
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
10. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D
Clin Evid; 2002 Jun; (7):1344-57. PubMed ID: 12243121
[No Abstract] [Full Text] [Related]
12. [Other drugs (not bronchodilators) in COPD].
García Río F
Arch Bronconeumol; 2004 Mar; 40 Suppl 1():34-40. PubMed ID: 16137448
[No Abstract] [Full Text] [Related]
13. Efficacy of carbocisteine in the treatment of chronic obstructive pulmonary disease and impact on the quality of life.
Alibašić E; Skopljak A; Čengić A; Krstović G; Trifunović N; Čatić T; Kapo B; Mehić M; Hadžimuratović A
Med Glas (Zenica); 2017 Aug; 14(2):182-188. PubMed ID: 28786969
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
15. Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease.
Black PN; McDonald CF
Postgrad Med J; 2009 Mar; 85(1001):141-7. PubMed ID: 19351641
[TBL] [Abstract][Full Text] [Related]
16. [Role of inhaled corticosteroids in the management of COPD].
Chazan R
Pneumonol Alergol Pol; 2009; 77(2):186-91. PubMed ID: 19462354
[No Abstract] [Full Text] [Related]
17. [Inhaled corticosteroids in COPD--between pro and con?].
Mihalţan F
Pneumologia; 2009; 58(4):204-5. PubMed ID: 20067052
[No Abstract] [Full Text] [Related]
18. Inhaled corticosteroids for chronic obstructive pulmonary disease: a status report.
Niewoehner DE; Wilt TJ
Am J Respir Crit Care Med; 2007 Jan; 175(2):103-4. PubMed ID: 17200504
[No Abstract] [Full Text] [Related]
19. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; ten Hacken N
Clin Evid; 2005 Jun; (13):1923-47. PubMed ID: 16135316
[No Abstract] [Full Text] [Related]
20. Ethics of placebo controlled studies of inhaled steroids for COPD.
Hahn DL
Thorax; 2004 Jun; 59(6):539; author reply 539-40. PubMed ID: 15170046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
